Table 2.
Plasma IL18, MMP-22, and MMP-29 are independent risk factors of human CHD
| Dependent variable | CHD status | Logarithmized data# | OR (95% CI) | Adjusted OR (95% CI) |
| ln(IL18) | CHD | 0.98 (0.81, 1.42) | 1.131 (1.027, 1.751) | 1.021 (1.001, 1.369) |
| Non-CHD | 0.84 (0.00, 1.00) | |||
| P | 0.002* | 0.007** | 0.005*** | |
| ln(MMP-22) | CHD | 0.15 (0.01, 0.51) | 1.213 (1.041, 2.529) | 1.092 (1.013, 1.777) |
| Non-CHD | 0.01 (0.00, 0.06) | |||
| P | 0.026* | 0.040** | 0.011*** | |
| ln(MMP-29) | CHD | 2.13 (2.01, 2.42) | 1.198 (1.039, 2.380) | 1.082 (1.011, 1.775) |
| Non-CHD | 2.04 (1.99, 2.10) | |||
| P | 0.009* | 0.033** | 0.012*** |
Data are expressed as ln(IL18) (ng/dl), ln(MMP-22) (ng/ml), and ln(MMP-29) (ng/ml) at percentile 50% (25%, 75%).
ANOVA test;
Logistic regression analysis;
Logistic regression analysis after adjusting for smoking, diabetes, hypertension, age, and sex